ArticlePloS one2015

Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation without Affecting HbA1c in Type 2 Diabetic db/db Mice.

Christopher Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.